172 related articles for article (PubMed ID: 22706571)
1. Effect of intravenous vitamin C on cytokine activation and oxidative stress in end-stage renal disease patients receiving intravenous iron sucrose.
Conner TA; McQuade C; Olp J; Pai AB
Biometals; 2012 Oct; 25(5):961-9. PubMed ID: 22706571
[TBL] [Abstract][Full Text] [Related]
2. Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose.
Pai AB; Conner T; McQuade CR; Olp J; Hicks P
Biometals; 2011 Aug; 24(4):603-13. PubMed ID: 21229380
[TBL] [Abstract][Full Text] [Related]
3. The effect of intravenous iron on oxidative stress in hemodialysis patients at various levels of vitamin C.
Eiselt J; Racek J; Opatrný K; Trefil L; Stehlík P
Blood Purif; 2006; 24(5-6):531-7. PubMed ID: 17077626
[TBL] [Abstract][Full Text] [Related]
4. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
Pai AB; Boyd AV; McQuade CR; Harford A; Norenberg JP; Zager PG
Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
[TBL] [Abstract][Full Text] [Related]
6. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
[TBL] [Abstract][Full Text] [Related]
7. Effects of intravenous iron on mononuclear cells during the haemodialysis session.
Martin-Malo A; Merino A; Carracedo J; Alvarez-Lara MA; Ojeda R; Soriano S; Crespo R; Ramirez R; Aljama P
Nephrol Dial Transplant; 2012 Jun; 27(6):2465-71. PubMed ID: 22207322
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C supplementation decreases oxidative stress biomarker f2-isoprostanes in plasma of nonsmokers exposed to environmental tobacco smoke.
Dietrich M; Block G; Benowitz NL; Morrow JD; Hudes M; Jacob P; Norkus EP; Packer L
Nutr Cancer; 2003; 45(2):176-84. PubMed ID: 12881011
[TBL] [Abstract][Full Text] [Related]
9. The effect of serum albumin level on iron-induced oxidative stress in chronic renal failure patients.
Sezer MT; Akin H; Demir M; Erturk J; Aydin ZD; Savik E; Tunc N
J Nephrol; 2007; 20(2):196-203. PubMed ID: 17514624
[TBL] [Abstract][Full Text] [Related]
10. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress from rapid versus slow intravenous iron replacement in haemodialysis patients.
Tiranathanagul K; Eiam-Ong S; Tosukhowong P; Praditpornsilpa K; Tungsanga K
Nephrology (Carlton); 2004 Aug; 9(4):217-22. PubMed ID: 15363053
[TBL] [Abstract][Full Text] [Related]
12. The effect of different doses and types of intravenous iron on oxidative stress and inflammation in hemodialysis patients.
Kumbasar A; Gursu M; Kaya C; Ozturk S; Ergen A; Kemik A; Aydin Z; Uzun S; Karadag S; Kazancioglu R
J Nephrol; 2012; 25(5):825-32. PubMed ID: 22307439
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravenous iron sucrose on oxidative stress in peritoneal dialysis patients.
Saglam F; Cavdar C; Uysal S; Cavdar Z; Camsari T
Ren Fail; 2007; 29(7):849-54. PubMed ID: 17994454
[TBL] [Abstract][Full Text] [Related]
14. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy.
Adhikary L; Acharya S
JNMA J Nepal Med Assoc; 2011; 51(183):133-6. PubMed ID: 22922860
[TBL] [Abstract][Full Text] [Related]
16. Oral vitamin C administration increases lipid peroxidation in hemodialysis patients.
De Vriese AS; Borrey D; Mahieu E; Claeys I; Stevens L; Vanhaeverbeke A; Roelens M; Langlois MR
Nephron Clin Pract; 2008; 108(1):c28-34. PubMed ID: 18087169
[TBL] [Abstract][Full Text] [Related]
17. Does IV Iron Induce Plasma Oxidative Stress in Critically Ill Patients? A Comparison With Healthy Volunteers.
Lasocki S; Piednoir P; Couffignal C; Rineau E; Dufour G; Lefebvre T; Puy H; Duval X; Driss F; Schilte C
Crit Care Med; 2016 Mar; 44(3):521-30. PubMed ID: 26605680
[TBL] [Abstract][Full Text] [Related]
18. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
19. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress.
Yang CC; Hsu SP; Wu MS; Hsu SM; Chien CT
Kidney Int; 2006 Feb; 69(4):706-14. PubMed ID: 16395251
[TBL] [Abstract][Full Text] [Related]
20. Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis.
Salahudeen AK; Oliver B; Bower JD; Roberts LJ
Kidney Int; 2001 Oct; 60(4):1525-31. PubMed ID: 11576368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]